Antihypertensive blockers of Ang II receptors have been effective in inhibiting the production of IL-6, TNF-α, and receptor activator of the nuclear factor kappa-Β ligand, and consequently, they reduce alveolar bone loss in rats with experimental periodontitis [36,37]. The gene discussed is TNF; the disease is periodontitis.